119 related articles for article (PubMed ID: 2661772)
1. Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine?
Cooper DK; Novitzky D; Davis L; Huff JE; Parker D; Schlesinger R; Sholer C; Zuhdi N
J Heart Transplant; 1989; 8(3):221-4. PubMed ID: 2661772
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.
de Groen PC; Aksamit AJ; Rakela J; Forbes GS; Krom RA
N Engl J Med; 1987 Oct; 317(14):861-6. PubMed ID: 3306386
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine neurotoxicity in heart transplantation.
Vázquez de Prada JA; Martín-Duran R; García-Monco C; Calvo JR; Olalla JJ; González-Vilchez F; Gutierrez JA
J Heart Transplant; 1990; 9(5):581-3. PubMed ID: 2231100
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure after heart transplantation and cyclosporine therapy.
McGiffin DC; Kirklin JK; Naftel DC
J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
[TBL] [Abstract][Full Text] [Related]
5. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation.
Atkinson K; Biggs J; Darveniza P; Boland J; Concannon A; Dodds A
N Engl J Med; 1984 Feb; 310(8):527. PubMed ID: 6363932
[No Abstract] [Full Text] [Related]
7. Cyclosporine in heart and heart-lung transplantation.
Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
[TBL] [Abstract][Full Text] [Related]
8. Heart transplantation in Paris, at "La Pitie" Hospital.
Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P
J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522
[No Abstract] [Full Text] [Related]
9. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiac rejection in heart and heart-lung transplantation.
Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
[TBL] [Abstract][Full Text] [Related]
11. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
Tolkoff-Rubin NE; Rubin RH
Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
[No Abstract] [Full Text] [Related]
12. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041
[No Abstract] [Full Text] [Related]
13. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-associated renal arteriopathy.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
[No Abstract] [Full Text] [Related]
15. Kidney function in heart-lung transplant recipients: the effect of low-dosage cyclosporine therapy.
Imoto EM; Glanville AR; Baldwin JC; Theodore J
J Heart Transplant; 1987; 6(4):204-13. PubMed ID: 3117987
[TBL] [Abstract][Full Text] [Related]
16. Combined heart-lung transplantation for terminal pulmonary lymphangioleiomyomatosis.
Wellens F; Estenne M; de Francquen P; Goldstein J; Leclerc JL; Primo G
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):872-6. PubMed ID: 3923274
[TBL] [Abstract][Full Text] [Related]
17. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
[No Abstract] [Full Text] [Related]
18. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
Lough ME; Miller JL; Gamberg P
J Heart Transplant; 1986; 5(4):322-6. PubMed ID: 3305825
[TBL] [Abstract][Full Text] [Related]
19. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature.
Drachman BM; DeNofrio D; Acker MA; Galetta S; Loh E
J Heart Lung Transplant; 1996 Nov; 15(11):1158-64. PubMed ID: 8956125
[TBL] [Abstract][Full Text] [Related]
20. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
